Skip to main content
NASDAQ:QTRX

Quanterix Stock Forecast, Price & News

$44.98
-0.71 (-1.55 %)
(As of 05/17/2021 12:00 AM ET)
Add
Compare
Today's Range
$44.00
$45.63
50-Day Range
$43.30
$67.00
52-Week Range
$23.87
$92.57
Volume250,195 shs
Average Volume416,183 shs
Market Capitalization$1.63 billion
P/E RatioN/A
Dividend YieldN/A
Beta1.71
30 days | 90 days | 365 days | Advanced Chart
Receive QTRX News and Ratings via Email

Sign-up to receive the latest news and ratings for Quanterix and its competitors with MarketBeat's FREE daily newsletter.


Quanterix logo

About Quanterix

Quanterix Corporation, a life sciences company, develops and markets digital immunoassay platforms that advances precision health for life sciences research and diagnostics in North America, Europe, the Middle East, Africa, and the Asia Pacific regions. The company offers HD-X instrument, a sensitive automated multiplex protein detection platform; and SR-X instrument that enables researchers to apply Simoa detection technology in various applications, including direct detection of nucleic acids. It also provides SP-X instrument that is based on Simoa planar array technology for the measurement of multiplex chemiluminescent immunoassays. The company's products include assay kits and other consumables such as reagents. In addition, it offers contract research services, including sample testing, homebrew assay development, and custom development services. The company primarily operates in the areas of neurology, oncology, cardiology, infectious diseases, and inflammation. It sells its products for the life science research sector primarily to laboratories associated with academic and governmental research institutions, as well as pharmaceutical, biotechnology, and contract research companies through a direct sales force, support organizations, and distributors or sales agents. The company was formerly known as Digital Genomics, Inc. and changed its name to Quanterix Corporation in August 2007. Quanterix Corporation was incorporated in 2007 and is headquartered in Billerica, Massachusetts.

Headlines

See More Headlines

Industry, Sector and Symbol

Industry Analytical instruments
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:QTRX
CUSIPN/A
Phone617-301-9400
Employees314
Year FoundedN/A

Sales & Book Value

Annual Sales$56.73 million
Book Value$4.59 per share

Profitability

Net Income$-40,800,000.00

Debt

Price-To-Earnings

Miscellaneous

Market Cap$1.63 billion
Next Earnings Date8/3/2021 (Estimated)
OptionableNot Optionable

MarketRank

Overall MarketRank

1.62 out of 5 stars

Medical Sector

398th out of 2,032 stocks

Analytical Instruments Industry

10th out of 29 stocks

Analyst Opinion: 3.5Community Rank: 2.3Dividend Strength: 0.0Insider Behavior: 1.7Valuation: 0.6 5 -4 -3 -2 -1 -
speech bubbles
speech bubbles











Quanterix (NASDAQ:QTRX) Frequently Asked Questions

Is Quanterix a buy right now?

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Quanterix in the last year. There are currently 3 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" Quanterix stock.
View analyst ratings for Quanterix
or view top-rated stocks.

What stocks does MarketBeat like better than Quanterix?

Wall Street analysts have given Quanterix a "Buy" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Quanterix wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

When is Quanterix's next earnings date?

Quanterix is scheduled to release its next quarterly earnings announcement on Tuesday, August 3rd 2021.
View our earnings forecast for Quanterix
.

How were Quanterix's earnings last quarter?

Quanterix Co. (NASDAQ:QTRX) issued its quarterly earnings data on Wednesday, May, 5th. The company reported ($0.29) earnings per share for the quarter, beating the consensus estimate of ($0.32) by $0.03. Quanterix had a negative net margin of 41.69% and a negative trailing twelve-month return on equity of 22.37%.
View Quanterix's earnings history
.

How has Quanterix's stock price been impacted by Coronavirus (COVID-19)?

Quanterix's stock was trading at $18.51 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, QTRX shares have increased by 143.0% and is now trading at $44.98.
View which stocks have been most impacted by COVID-19
.

What price target have analysts set for QTRX?

3 Wall Street analysts have issued twelve-month price objectives for Quanterix's shares. Their forecasts range from $40.00 to $90.00. On average, they expect Quanterix's share price to reach $66.67 in the next twelve months. This suggests a possible upside of 48.2% from the stock's current price.
View analysts' price targets for Quanterix
or view top-rated stocks among Wall Street analysts.

Who are Quanterix's key executives?

Quanterix's management team includes the following people:
  • Mr. E. Kevin Hrusovsky, Chairman, Pres & CEO (Age 59, Pay $1.31M)
  • Dr. David R. Walt, Co-Founder, Chairman of Scientific Advisory Board & Independent Director (Age 68, Pay $41k)
  • Mr. Amol Chaubal, CFO & Treasurer (Age 45, Pay $501.87k)
  • Mr. John J. Fry, Gen. Counsel & Corp. Sec. (Age 60, Pay $465k)
  • Mr. Bruce J. Bal, VP of Operations, Service & Quality (Age 62)
  • Mr. William Geist, Chief Operating Officer (Age 52)
  • Dr. David C. Duffy Ph.D., Sr. VP of R&D and CTO (Age 50)
  • David Panzerella, VP of Sales
  • Dr. Mark T. Roskey, Sr. VP of Strategic Partnerships (Age 61)
  • Dr. Dawn R. Mattoon Ph.D., Sr. VP of Diagnostics (Age 48)

What is Kevin Hrusovsky's approval rating as Quanterix's CEO?

15 employees have rated Quanterix CEO Kevin Hrusovsky on Glassdoor.com. Kevin Hrusovsky has an approval rating of 70% among Quanterix's employees.

Who are some of Quanterix's key competitors?

What other stocks do shareholders of Quanterix own?

When did Quanterix IPO?

(QTRX) raised $50 million in an initial public offering on Thursday, December 7th 2017. The company issued 3,300,000 shares at $14.00-$16.00 per share. J.P. Morga and Leerink Partners served as the underwriters for the IPO and BTIG and Evercore ISI were co-managers.

What is Quanterix's stock symbol?

Quanterix trades on the NASDAQ under the ticker symbol "QTRX."

Who are Quanterix's major shareholders?

Quanterix's stock is owned by a variety of retail and institutional investors. Top institutional shareholders include Gilder Gagnon Howe & Co. LLC (8.06%), Price T Rowe Associates Inc. MD (5.79%), BlackRock Inc. (5.27%), Lord Abbett & CO. LLC (3.58%), Ameriprise Financial Inc. (2.81%) and Victory Capital Management Inc. (1.94%). Company insiders that own Quanterix stock include Amol Chaubal, David C Duffy, David R Walt, Dawn Mattoon, E Kevin Hrusovsky, John J Fry, Marijn E Dekkers, Mark T Roskey and Martin D Madaus.
View institutional ownership trends for Quanterix
.

Which major investors are selling Quanterix stock?

QTRX stock was sold by a variety of institutional investors in the last quarter, including Monashee Investment Management LLC, Gilder Gagnon Howe & Co. LLC, Ameriprise Financial Inc., Royce & Associates LP, Bridger Management LLC, Ashford Capital Management Inc., Kornitzer Capital Management Inc. KS, and JPMorgan Chase & Co.. Company insiders that have sold Quanterix company stock in the last year include Amol Chaubal, David C Duffy, Dawn Mattoon, E Kevin Hrusovsky, John J Fry, Marijn E Dekkers, Mark T Roskey, and Martin D Madaus.
View insider buying and selling activity for Quanterix
or view top insider-selling stocks.

Which major investors are buying Quanterix stock?

QTRX stock was bought by a variety of institutional investors in the last quarter, including Lord Abbett & CO. LLC, Price T Rowe Associates Inc. MD, Victory Capital Management Inc., Baillie Gifford & Co., Goldman Sachs Group Inc., Waddell & Reed Financial Inc., Sectoral Asset Management Inc, and Bank Julius Baer & Co. Ltd Zurich.
View insider buying and selling activity for Quanterix
or or view top insider-buying stocks.

How do I buy shares of Quanterix?

Shares of QTRX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Quanterix's stock price today?

One share of QTRX stock can currently be purchased for approximately $44.98.

How much money does Quanterix make?

Quanterix has a market capitalization of $1.63 billion and generates $56.73 million in revenue each year. The company earns $-40,800,000.00 in net income (profit) each year or ($1.63) on an earnings per share basis.

How many employees does Quanterix have?

Quanterix employs 314 workers across the globe.

What is Quanterix's official website?

The official website for Quanterix is www.quanterix.com.

Where are Quanterix's headquarters?

Quanterix is headquartered at 900 MIDDLESEX TURNPIKE, BILLERICA MA, 01821.

How can I contact Quanterix?

Quanterix's mailing address is 900 MIDDLESEX TURNPIKE, BILLERICA MA, 01821. The company can be reached via phone at 617-301-9400 or via email at [email protected]


This page was last updated on 5/18/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.